The significance of GPR119 agonists as a future treatment for type 2 diabetes.
about
A categorical structure-activity relationship analysis of GPR119 ligands.Update on the treatment of type 2 diabetes mellitusStructure-activity relationships of fatty acid amide ligands in activating and desensitizing G protein-coupled receptor 119.Structural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119.The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119.Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes.
P2860
The significance of GPR119 agonists as a future treatment for type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The significance of GPR119 agonists as a future treatment for type 2 diabetes.
@en
The significance of GPR119 agonists as a future treatment for type 2 diabetes.
@nl
type
label
The significance of GPR119 agonists as a future treatment for type 2 diabetes.
@en
The significance of GPR119 agonists as a future treatment for type 2 diabetes.
@nl
prefLabel
The significance of GPR119 agonists as a future treatment for type 2 diabetes.
@en
The significance of GPR119 agonists as a future treatment for type 2 diabetes.
@nl
P1476
The significance of GPR119 agonists as a future treatment for type 2 diabetes.
@en
P2093
Shalinee Dhayal
P304
P356
10.1358/DNP.2010.23.7.1468395
P577
2010-09-01T00:00:00Z